Shore Team

Ryan is a Founding Partner of Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Mike Cooper

Mike is a Founding Partner of Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

John Hennegan

John is a Founding Partner of Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Don Pierce

Don is a Partner at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA

Richard Boos

Richard is a Partner at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA. Richard is the Chairman of Main Street Gourmet, Old World Spices & Seasonings, and Innovative Packaging Company, and is responsible for leading the Shore Food and Beverage Fund including the sourcing and evaluation of investment opportunities and operating executives.

Chris Mioton

Chris is a Partner at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Steve Malley

Steve is a Partner at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Brad Morehead

Chief of Strategy and Talent Development

Brad Morehead is a Partner at Shore Capital, a microcap private equity fund focused on partnering with business services companies that have between $1-10 million of EBITDA Brad is responsible for Business Services investment sourcing and valuation, transaction structuring, and corporate development. Brad is on the board of Point C, Assembly Health, and Tandem HR.

James E. Forrest

Chairman

James E. Forrest currently serves as Chairman of Shore Capital, a Chicago-based private equity group focused on health care services and the food industry

Michael Burcham

Michael is an entrepreneur, investor and healthcare strategist with 30 years’ experience leading technology-enabled healthcare organizations.

Sean McEnroe

Executive Partner

Sean McEnroe serves on multiple equity backed, multi-site healthcare, start-up, and non-profit boards.

Paul Rutledge

Executive Partner

Paul is an Executive Partner at Shore Capital Partners. He currently serves as a Director for SouthStar Urgent Care and SENTA, Shore Capital portfolio companies. Paul previously served as President and CEO of CHC Holdings, the Chinese health care venture backed by the Frist family. Until retiring in 2013, Paul spent 30 years at HCA, rising to president of its 61-hospital Central Group. Paul joined HCA in 1982 as COO in the company’s New Orleans market and has held a number of leadership positions within the system. Prior to this, He served as President of TriStar Health System from June 1996 to January 2001 and served as President of Centennial Medical Center from May 1993 to June 1996.

Tom Smithburg

Tom is a Principal at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Rory Kenny

Rory is a Principal at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Matt Sweeney

Matt is a Principal at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Jeff Smith

Jeff is a Principal at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Jeff Smart

Jeff is a Principal at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Mickey Jiang

Mickey is a Principal at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA

Jon Tomberlin

Jon is a Senior Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have $1-10 million of EBITDA.

Mike Oleferchik

Mike is a Senior Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Ankeet Patel

Ankeet is a Senior Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Alex Nevill

Alex is a Senior Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Matt Brown

Matt is a Vice President atShore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA. Matt’s responsibilities include sourcing, evaluating, and enabling the growth of Shore investments. He is actively involved with Shore’s investments in Golden Bear Physical Therapy,Assembly Health, and SENTA.

Matt Matosian

Matt is a Vice President at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA. Matt’s responsibilities include sourcing, evaluating, and enabling the growth of Shore’s investments in the food and beverage industry.

Adam Pegram

Adam is a Vice President at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA

Logan Pitts

Logan is a Vice President at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA. Logan’s responsibilities include sourcing, evaluating, and executing platform investments and supporting the growth of current portfolio companies in the healthcare industry.

Cole Michalek

Cole is an Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Adam Boudjemai

Adam is an Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Max Martineau

Max is an Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Colin North

Colin is an Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

Alex Fordham

Alex is an Analyst at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-$10 million of EBITDA.

John Hazen

John is an Analyst at Shore Capital Partners, a microcap private equity firm focused on partnering with companies that have between $1-$10 million of EBITDA.

Tim Sharky

Tim is an Analyst at Shore Capital Partners, a microcap private equity firm focused on partnering with companies that have between $1-$10 million of EBITDA.

Jack Harrington

Jack is an Analyst at Shore Capital Partners, a microcap private equity firm focused on partnering with companies that have between $1-$10 million of EBITDA.

AJ Gauthier

AJ is an Associate at Shore Capital, a microcap private equity firm focused on partnering with companies that have between $1-10 million of EBITDA.

David Clancy

David is an Analyst at Shore Capital Partners, a microcap private equity firm focused on partnering with companies that have between $1-$10 million of EBITDA.

Nick DeSalvo

Nick is an Analyst at Shore Capital Partners, a microcap private equity firm focused on partnering with companies that have between $1-$10 million of EBITDA.

Chris Sullivan

Chris is an Analyst at Shore Capital Partners, a microcap private equity firm focused on partnering with companies that have between $1-$10 million of EBITDA. Chris is responsible for conducting due diligence on new investment opportunities and implementing value creation initiatives within portfolio investments.

Chris Galla

Richard Rolapp

Richard is an Analyst at Shore Capital Partners, a microcap private equity firm focused on partnering with companies that have between $1-$10 million of EBITDA. Richard is responsible for conducting due diligence on new investment opportunities and implementing value creation initiatives within portfolio investments.

Saanchi Bhatia